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Introduction
Heart failure is common in adult congenital heart disease
(ACHD) and may be secondary to myocardial fibrosis.
Purpose
We sought to quantify diffuse fibrosis using the volume of
distribution of Gadolinium (VdGd).
Methods
Consecutive ACHD patients (N = 15) were studied with
cardiac MRI (Philips Achieva 3.0 Tesla) to quantify ven-
tricular volume and function, as well as late gadolinium
enhancement (LGE). T1 measurements were made with a
Look-Locker technique, ie GRE sequence with a non-slice
selective inversion pulse followed by segmented GRE
acquisition for 20–24 cardiac phases. (temporal resolu-
tion 40 ms, TR/TE/FA = 3.4/1.7/12, slice thickness 8 mm,
170 × 140 matrix, FOV 400 × 320 – 400, SENSE factor 2)
The sequence was performed before and at various inter-
vals 3–15 minutes after injection of Gadolinium-DTPA
(total dose 0.1 mmol/kg). For each T1 sequence a region
of interest was defined for the myocardium of the sys-
temic ventricle and blood pool. Intensity vs. time curves
were used to define T1, and 1/T1 or RT1. The slope of the
linear relationship of RT1 values for myocardium vs. blood
gave the partition coefficient of Gadolinium (lambda).
VdGd was calculated as lambda × (1-Hct/100). Results
were compared to normal controls (N = 10) and patients
with acquired heart failure (N = 4).
Results
VdGd was significantly elevated in ACHD patients com-
pared to controls (32 ± 5% vs. 25 ± 2%, p < 0.001). There
was a negative correlation between VdGd and systemic
ventricular ejection fraction (R = -0.43). VdGd was com-
parable to patients with acquired heart disease (29 ± 5%,
p = ns; p = 0.016 vs. controls), similar to our previously
reported values in cardiomyopathy patients. No large
macroscopic areas of LGE were present to explain the find-
ings. VdGd was highest in patients with transposition of
the great arteries (35 ± 5%) and Eisenmenger syndrome
(34 ± 5%).
Conclusion
ACHD patients have evidence of diffuse, microscopic
myocardial fibrosis, similar to patients with acquired
heart disease such as cardiomyopathy, not shown by LGE.
VdGd may facilitate much needed studies on mechanism
and therapies for myocardial fibrosis in these patients.
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